Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the long-term risks of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) secondary to weight gain and clinical obesity associated with the initiation of integrase strand transfer inhibitors and tenofovir alafenamide (TAF) in the ADVANCE trial using validated risk equation tools. DESIGN: Retrospective data analysis. METHODS: In ADVANCE, 1053 treatment-naive participants in South Africa (99% black, 59% female) were randomized to 96 weeks of TAF/emtricitabine + dolutegravir (TAF/FTC + DTG), tenofovir disoproxil fumarate/FTC + DTG (TDF/FTC + DTG), or TDF/FTC + efavirenz (TDF/FTC/EFV). The 5 and 10-year risks of CVD were calculated using D:A:D, QRISK and Framingham, and T2DM risk using QDiabetes, Cambridge Diabetes and Leicester Practice Risk scores. Participants were included in this analysis if they were above 30 years old at baseline. RESULTS: A total of 217 (TAF/FTC + DTG), 218 (TDF/FTC + DTG), and 215 (TDF/FTC/EFV) participants had 96-week data available. Weight gain was +8.1, +4.2, and +2.4 kg on TAF/FTC + DTG, TDF/FTC + DTG, and TDF/FTC/EFV, respectively. Participants on TAF/FTC + DTG had greatest risk scores for CVD (using QRISK) and T2DM, driven by weight changes. Differences were statistically significant between TAF/FTC + DTG and TDF/FTC/EFV for CVD risk using the QRISK equation, equivalent to one extra case per 1000 people treated over 10 years, and between all treatment groups for T2DM risk. Six extra T2DM cases were predicted on TAF/FTC + DTG vs. TDF/FTC + DTG using QDiabetes. CONCLUSION: Obesity, especially with TAF/FTC + DTG, drove increased risk of T2DM, with some evidence of greater CVD risk. However, predictive tools have not been validated in the HIV-positive and black African population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · cited 9×
“:D and Framingham equations.”
MethodInfluentialAlberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Global nutrition transition and the pandemic of obesity in developing countries
Popkin, B. M., Adair, L. S., & Ng, S. W. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00456.x · Cited by 4,313 · cited 1×
“Obesity is on the rise in the sub-Saharan Africa; a consequence of urbanization and changing lifestyle [7,8].”
BackgroundHaslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633
Gender differences in coronary heart disease
Maas, A. H. E. M., & Appelman, Y. E. A. (2010) · Netherlands Heart Journal · doi:10.1007/s12471-010-0841-y · Cited by 983
Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033369 · Cited by 975
Brown, T. T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1179 · Cited by 851
Cited by
Horberg, M. A., Thompson, M., Agwu, A. L., Colasanti, J. A., Haddad, M. S., Jain, M. K., McComsey, G. A., Radix, A., Rakhmanina, N. Y., Short, W. R., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae479 · Cited by 189
Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease
Obare, L. M., Temu, T. M., Mallal, S. A., & Wanjalla, C. N. (2024) · Circulation Research · doi:10.1161/circresaha.124.323891 · Cited by 169
Wood, B. R., & Huhn, G. D. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab542 · Cited by 83
Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV
Eke, A. C., Mirochnick, M. H., & Lockman, S. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2212877 · Cited by 78
Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications
Chandiwana, N. C., Siedner, M. J., Marconi, V. C., Hill, A. M., Ali, M. K., Batterham, R. L., & Venter, F. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad411 · Cited by 74
Self-citation
Metadata
- Authors
- McCann, K., Shah, S., Hindley, L., Hill, A., Qavi, A., Simmons, B., Serenata, C., Sokhela, S., & Venter, W. D. F.
- Affiliations
- Imperial College London (GB)
- University of Liverpool (GB)
- University of the Witwatersrand (ZA)
- Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Corresponding author
- McCann, Kaitlyn
- Shah, Shahini
- ORCID
- Venue
- AIDS
- Published
- 2021-04-28
- Volume
- 35
- Issue
- 10
- Pages
- 1657-1665
- ISSN
- 0269-9370 (ISSN-L)
- 1473-5571
- OpenAlex
- W3158467183
- Cited by
- 72
- References
- 53
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 17 · 2023: 22 · 2022: 12 · 2021: 6
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- weight gain, tenofovir alafenamide, tenofovir disoproxil fumarate, integrase strand transfer inhibitors, dolutegravir, efavirenz, HIV, type 2 diabetes, cardiovascular disease, obesity, cardiovascular risk prediction, diabetes risk prediction, ADVANCE trial, Black African population, antiretroviral-naive patients
- MeSH terms
- Emtricitabine, Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Retrospective Studies, South Africa, Weight Gain, HIV Infections, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes. https://app.cochat.ai/papers/10.1097/qad.0000000000002930
- The paper
- McCann, K., Shah, S., Hindley, L., Hill, A., Qavi, A., Simmons, B., Serenata, C., Sokhela, S., & Venter, W. D. F. (2021). Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes. AIDS. https://doi.org/10.1097/qad.0000000000002930
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.